---
document_datetime: 2025-02-11 16:05:50
document_pages: 8
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/armisarte-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: armisarte-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 4.7948527
conversion_datetime: 2025-12-22 00:47:16.464812
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Armisarte

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                            | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                   |
|----------------------|--------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/2330/ 202402   | Periodic Safety Update EU Single assessment - pemetrexed                                         | 17/10/2024                          | 12/12/2024                                  | SmPC and PL                      | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/2330/202402. |
| N/0033               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 16/10/2023                          | 10/05/2024                                  | Labelling and PL                 |                                                                                                                                           |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The

CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IG/1612   | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 31/05/2023   | 11/08/2023   | SmPC, Labelling and PL   |                        |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------|------------------------|
| II/0030/G | This was an application for a group of variations. B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range B.II.d.1.c - Change in the specification parameters and/or limits of the finished product - Addition of a new specification parameter to the specification with its corresponding test method B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure | 23/03/2023   | n/a          |                          | (including replacement |
| IB/0031   | B.II.f.1.z - Stability of FP - Change in the shelf-life or storage conditions of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 18/01/2023   | 11/08/2023   | SmPC, Labelling and PL   |                        |
| IB/0029   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO data is required to be submitted by                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 24/08/2022   | 11/08/2023   | SmPC, Annex II and PL    | new additional         |

<div style=\"page-break-after: always\"></div>

|                    | the MAH                                                                                                                                                                        |            |            |                        |                                                                                                                                                                                                                                                                         |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/2330/ 202102 | Periodic Safety Update EU Single assessment - pemetrexed                                                                                                                       | 30/09/2021 | n/a        |                        | PRAC Recommendation - maintenance                                                                                                                                                                                                                                       |
| IB/0027            | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                 | 03/08/2021 | 01/07/2022 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                         |
| IAIN/0028          | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                             | 02/08/2021 | n/a        |                        |                                                                                                                                                                                                                                                                         |
| IB/0024            | B.II.f.1.z - Stability of FP - Change in the shelf-life or storage conditions of the finished product - Other variation                                                        | 29/06/2021 | 01/07/2022 | SmPC, Labelling and PL | To include the dilution of Pemetrexed 25 mg/mL concentrate for solution for infusion in 0.9% sodium chloride to maintain the dilution stable for 24 hours at 25oC and 7 days at 2oC - 8oC.                                                                              |
| IA/0026            | B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information | 08/06/2021 | n/a        |                        |                                                                                                                                                                                                                                                                         |
| IAIN/0023          | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                             | 22/04/2021 | n/a        |                        |                                                                                                                                                                                                                                                                         |
| R/0022             | Renewal of the marketing authorisation.                                                                                                                                        | 25/06/2020 | 13/08/2020 | SmPC, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Armisarte in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |

<div style=\"page-break-after: always\"></div>

| IB/0021            | B.II.f.1.a.3 - Stability of FP - Reduction of the shelf life of the finished product - After dilution or reconstitution                                                                                                                                                                                                                                                                                        | 26/03/2020   | 13/08/2020   | SmPC and PL   |                                                                                                                                           |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|---------------|-------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0020            | B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter)                                                                                                                                                                                            | 17/03/2020   | n/a          |               |                                                                                                                                           |
| PSUSA/2330/ 201802 | Periodic Safety Update EU Single assessment - pemetrexed                                                                                                                                                                                                                                                                                                                                                       | 18/10/2018   | 15/01/2019   | SmPC and PL   | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/2330/201802. |
| IB/0019            | B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data                                                                                                                                                                                                                                         | 18/12/2018   | n/a          |               |                                                                                                                                           |
| II/0017/G          | This was an application for a group of variations. B.II.d.1.f - Change in the specification parameters and/or limits of the finished product - Deletion of a specification parameter which may have a significant effect on the overall quality of the finished product B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) | 13/09/2018   | n/a          |               |                                                                                                                                           |
| IAIN/0016          | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                 | 10/04/2018   | 15/01/2019   | SmPC and PL   |                                                                                                                                           |

<div style=\"page-break-after: always\"></div>

| IB/0014   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                       | 10/10/2017   | 25/05/2018   | SmPC, Labelling and PL   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------|
| IA/0015   | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                                                                                                                                                                                                                                                                                         | 28/09/2017   | n/a          |                          |
| IAIN/0013 | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                                                                                                                                                                                             | 28/09/2017   | 25/05/2018   | Annex II and PL          |
| II/0008/G | This was an application for a group of variations. B.II.a.3.b.2 - Changes in the composition (excipients) of the finished product - Other excipients - Qualitative or quantitative changes in one or more excipients that may have a significant impact on the safety, quality or efficacy of the product B.II.e.5.c - Change in pack size of the finished product - Change in the fill weight/fill volume of sterile multidose (or single-dose, partial use) parenteral medicinal products, including biological/immunological medicinal products | 18/05/2017   | 25/05/2018   | SmPC, Labelling and PL   |

<div style=\"page-break-after: always\"></div>

| IA/0011   | A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient                                                                                                                                                                                                                                               | 05/04/2017   | n/a   |                                      |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|--------------------------------------|
| IB/0009/G | This was an application for a group of variations. B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process B.II.e.4.c - Change in shape or dimensions of the container or closure (immediate packaging) - Sterile                                                                                                                                                                                             | 25/01/2017   | n/a   | medicinal products                   |
| IB/0007   | B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data                                                                                                                                                                                                                                                                                                                     | 05/01/2017   | n/a   |                                      |
| IB/0006/G | This was an application for a group of variations. B.II.b.1.f - Replacement or addition of a manufacturing site for part or all of the manufacturing process of the FP - Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products B.II.b.3.a - Change in the manufacturing process of | 21/09/2016   | n/a   | the finished or intermediate product |

<div style=\"page-break-after: always\"></div>

|         | manufacturing process B.II.b.4.z - Change in the batch size (including batch size ranges) of the finished product - Other variation B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation B.II.e.2.z - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Other variation B.II.e.4.c - Change in shape or dimensions of the container or closure (immediate packaging) - Sterile medicinal products B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information   |            |            |             | in the   |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|----------|
| N/0005  | Update of the package leaflet with revised contact details of the local representatives for Belgium, the Netherlands and Portugal. In addition, the MAH took the opportunity to make linguistic corrections in the Danish, German, Greek, Finnish, Hungarian, Icelandic, Italian, Latvian, Maltese, Dutch, Norwegian, Portuguese and Swedish labelling and package leaflets in line with the EN text. Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                           | 20/06/2016 | 16/02/2017 | PL          |          |
| IB/0003 | B.II.f.1.b.3 - Stability of FP - Extension of the shelf life of the finished product - After dilution or reconstitution (supported by real time data)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 11/03/2016 | 16/02/2017 | SmPC and PL |          |

<div style=\"page-break-after: always\"></div>

| IB/0002   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation   | 19/02/2016   | 16/02/2017   | SmPC and PL            |
|-----------|--------------------------------------------------------------------------------------------------|--------------|--------------|------------------------|
| IAIN/0001 | A.2.a - Administrative change - Change in the (invented) name of the medicinal product for CAPs  | 10/02/2016   | 16/02/2017   | SmPC, Labelling and PL |